Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

Current use of anti-hemostatics in ischemic cardiopathy

30-sep-1990 | Revista: Revista de Medicina de la Universidad de Navarra

Bolao I.G., Alegría E., Iglesias I., Velasco S., Fidalgo M.L., Gómez J.A., Huelmos A.
Departamento de Cardiología y Cirugía Cardiovascular, Facultad de Medicina, Universidad de Navarra, Pamplona, Spain.


Antihemostatic drugs are widely used in the treatment and prevention of ischemic heart disease.

Fibrinolytic agents are prescribed in the early phase of acute myocardial infarction, to reduce its size and improve survival. Their use in unstable angina is still controversial. Anticoagulants have substantial benefit in myocardial infarction, unstable angina and primary prevention of coronary disease.

Finally, antiplatelet agents are used in stable and unstable angina, myocardial infarction and high risk patients.

CITA DEL ARTÍCULO  Rev Med Univ Navarra. 1990 Oct-Dec;34(4):219-26

Nuestros autores